SAN FRANCISCO – Medtronic plc and Abbott Laboratories both reported a positive outlook and anticipated growth expected in 2018, following on payoffs from long-term strategy at the J.P. Morgan Healthcare Conference. Acquisitions and divestures were expected to add to the bottom line in the coming months, executive teams shared. Read More
